Naratriptan hydrochloride
SIGMA/N1415 - ≥98% (HPLC)
Synonym: Amerge; GR-85548A; N-
CAS Number: 143388-64-1
Empirical Formula (Hill Notation): C17H25N3O2S ·HCl
Molecular Weight: 371.93
MDL Number: MFCD08141821
Linear Formula: C17H25N3O2S ·HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C17H25N3O2S.ClH/c1-18- |
| InChI key | AWEZYKMQFAUBTD-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CNS(=O)(=O)CCc1ccc2[nH |
| solubility | H2O: ≥10 mg/mL |
| storage temp. | room temp |
| Biochem/physiol Actions: | Naratriptan hydrochloride is a serotonin 5-HT1B/1D receptor agonist. |
| Biochem/physiol Actions: | Naratriptan hydrochloride is a triptan drug that is used to relieve acute migraine headaches. It has poor bioavailability, short half-life, and the incidence of migraine recurrence therefore, it is occasionally used. |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


